我们应用免疫组化技术，选用我室制备的卵巢上皮癌相关抗原单抗COC166－9检测了192例卵巢和非卵巢肿瘤的石蜡切片，技试剂盒制备要求将单抗COC166－9制备成免疫组化试剂盒。结果表明：单抗COC166－9对卵巢上皮癌诊断的敏感性为91．57％．特异性79．82％，且对卵巢良恶性肿瘤、原发性和继发性卵巢癌的鉴别有临床价值。试剂盒质校试验表明已达到生物制品鉴定要求。 We use immunohistochemistry, using our room prepared ovarian epithelial cancer associated antigen monoclonal antibody COC166-9 detection of 192 cases of ovarian and non-ovarian tumor paraffin sections, kit preparation requires the monoclonal antibody COC166-9 prepared immune group Kits. The results showed that the sensitivity of McAb COC166-9 to the diagnosis of epithelial ovarian cancer was 91.57%. Specificity of 79.82%, and the benign and malignant ovarian tumors, primary and secondary ovarian cancer have clinical value. Kit proofreading test shows that biological products have reached the identification requirements.